The announcement comes just after Dexcom, another diabetes company, released its own consumer-friendly sensor. Here's what to ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Among the many corporations that pay a dividend, some do so unpredictably and irregularly. Others rarely raise their payouts ...

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...

Libre Flowers & Flames by YSL Beauty features a blend of coco-palm tree flower accord, lily flower, orange blossom and ...

Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a ...

Ltd. Boston Scientific (Bard® Stent System, Antibacterial Coating Technologies) Abbott Laboratories (Xience® Drug-Eluting ...

While existing investors celebrate its outstanding stock performance, potential investors may wonder if they should buy it ...